Master regulators of FGFR2 signalling and breast cancer risk - Test2 - elhamkhani - TriplyDB

Master regulators of FGFR2 signalling and breast cancer risk

Master regulators of FGFR2 signalling and breast cancer risk

http://www.wikidata.org/entity/Q37186448

about

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.Limited evidence that cancer susceptibility regions are preferential targets for somatic mutation Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.DFG-out mode of inhibition by an irreversible type-1 inhibitor capable of overcoming gate-keeper mutations in FGF receptors.Reverse engineering the neuroblastoma regulatory network uncovers MAX as one of the master regulators of tumor progression.Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia.Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis A Gene Regulatory Program in Human Breast Cancer Regulators of genetic risk of breast cancer identified by integrative network analysis.Sense-antisense gene-pairs in breast cancer and associated pathological pathways.The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study.FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets.Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.Inducible super-enhancers are organized based on canonical signal-specific transcription factor binding elements.The recurrent architecture of tumour initiation, progression and drug sensitivity.Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells.Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code.Differential expression of transcriptional regulatory units in the prefrontal cortex of patients with bipolar disorder: potential role of early growth response gene 3.Gene signature driving invasive mucinous adenocarcinoma of the lung.Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD).Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasia.HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway.Kinome-wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics.Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.Integrated Theory- and Data-driven Feature Selection in Gene Expression Data Analysis.Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway.Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.REGGAE: a novel approach for the identification of key transcriptional regulators

P2860

Q26799669-E46E1110-610B-4D09-B9A0-56EDAA0C5F39 Q27307642-F0756992-E0B0-496B-960A-1CE29ED945D4 Q34494290-C2168574-2E71-4435-8E54-08C59B3645CC Q34903062-16C736DF-FE4D-47AA-9487-915D2043E924 Q34992813-A81FB3D5-D22D-4B6D-98DF-BB8E3FD94E67 Q35070297-5BC6B538-E9C9-4C5F-9B70-F1D33C570C08 Q35619119-782C8E65-4032-45C3-8508-E5B2B6BF788F Q35782435-D82E0891-9166-4CF5-9E07-6D13EC6F69FB Q35796865-81C42253-3C87-4B2B-A902-A23891F62BFD Q35852820-3329BB98-C446-48D8-9238-1F51EB38F088 Q36229602-EEBDD37B-8681-4AD6-BFAF-3C0E736B8191 Q36264967-3FE41D53-8439-46EA-AD74-D3B062FB9392 Q36365236-C4F070DD-6DBA-47F4-9512-41EF639C08AB Q36419747-C2EBB977-97CB-4F6D-9DC2-715AF6D09321 Q36561721-A6C038F7-464E-47DC-9E7E-F1CD44D2F8C2 Q36754900-F247071B-FE62-4EB6-BE60-0A2FDAFCA24B Q37139660-A91B6CEB-3A27-4AA0-919E-5ABDAA466727 Q37605645-9A65ED90-B67D-42FB-99B2-587CABE6CD63 Q37711615-1C80FC7E-ECDC-49A0-AF19-E48F1751DF7E Q38720533-BA40187E-B775-4F08-9266-261737B21481 Q38725396-5CB86243-B4B9-4568-B599-61EB944A6EC4 Q39039006-699C10E4-71AE-47B9-8F05-B8F9AE68C325 Q39560851-F1F40700-6D1C-4F4E-AFCE-AD2D873E82F2 Q39752527-557AFA25-7A1E-4172-9139-845F01351952 Q39779714-7F85968F-95DC-412F-BE71-F0AACE921671 Q42293061-222E3F7C-4A27-40F5-A897-82ED045AFCFC Q42516513-E25A8A43-96D3-4F84-AEF0-B405AACCB073 Q46382588-494B441A-2AFD-4AE1-BC2E-596BA34890E3 Q47134720-D7914F20-42DA-409F-86A5-C9C1AD5925DB Q47295042-0913699C-40DA-4977-8890-45C261CFFD27 Q47708657-1F8327A6-E2C8-4908-A211-51C4BEC7D55A Q48607061-32C9E382-F57F-4487-801B-C10F07E0B784 Q49727374-54E5A6F6-1557-4904-82C1-1889402AFE08 Q52571267-3E4702A4-695F-4B95-888B-4F6E01B3F476 Q55499595-5DC545B8-39E3-4664-AE53-F00A30DD50AE Q57461511-36A1E24B-1DD8-4DC3-9D90-88DC607A2FD7

P2860

Master regulators of FGFR2 signalling and breast cancer risk

http://www.wikidata.org/entity/Q37186448

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Master regulators of FGFR2 signalling and breast cancer risk

@en

Master regulators of FGFR2 signalling and breast cancer risk.

@nl

type

label

Master regulators of FGFR2 signalling and breast cancer risk

@en

Master regulators of FGFR2 signalling and breast cancer risk.

@nl

prefLabel

Master regulators of FGFR2 signalling and breast cancer risk

@en

Master regulators of FGFR2 signalling and breast cancer risk.

@nl

P1433

Q37186448-E0480876-EDE2-46BC-B017-7FA817CBEAE8

P1476

Q37186448-0F562322-9490-4207-9DA5-6128C2C168D7

P2093

Q37186448-20FCA668-8AE4-4981-80CD-47C7B161F9AA

Q37186448-98573CB4-8D12-4E2F-BA4D-B1A55C065934

Q37186448-A38EC2B8-3966-4769-8410-4BA638E609DE

Q37186448-CFD41146-BDC4-4C1F-9E91-E3DF16341449

Q37186448-E00D03FB-FDAB-4F56-A21E-F5C690D279AE

Q37186448-F4BA721A-473A-45E6-A42B-2384098274CE

P2860

Q37186448-0137A512-F5F9-4F56-BDB5-F42E9E368AE0

Q37186448-045A5BFB-06D3-479F-9D2F-9CB17A3F8F93

Q37186448-0C7C1A56-FDB9-40B6-97B7-491BF862D287

Q37186448-1522E415-C61A-4243-AF71-07F9EDC614F4

Q37186448-17DDC42F-D594-40D3-BAA1-3CBD597E09B3

Q37186448-2207806D-0D4F-4950-9085-E5EE93EB77E1

Q37186448-233FFA4F-685F-4155-A333-C8DF6D39C92C

Q37186448-2BED06F1-BF29-4196-BC45-0C5FD200315F

Q37186448-30BD077B-E6C8-4980-8EFF-6C6B0E52B322

Q37186448-367F800D-81D9-4810-A1E0-A07D44E87704

P2888

Q37186448-2C2FC738-985D-484F-9EE8-A9D93F20AD85

P304

Q37186448-3838B001-37AD-4291-BD0E-1CE3C066A0E7

P31

Q37186448-75675D32-001B-4AB7-A74D-1D6F86D62A26

P356

Q37186448-48DD1ECB-2FDB-444D-AC22-6C0BC543D913

P407

Q37186448-45876DF8-C3BC-4503-87A1-7A3AC7D19537

P478

Q37186448-B465A719-D3B5-4625-8309-1C9217C718A0

P50

Q37186448-2AA8AC4F-3AA3-4A21-BEBF-860A9FE6C1BC

Q37186448-B872962C-9B77-42E6-A555-0FFEE839A09F

Q37186448-BC6D10A8-5818-49E7-810D-AA55E0E6126B

Q37186448-DD112415-2AD1-4C60-90CF-57E5344C6F5E

Q37186448-FC5C7DEF-DF8B-4F61-8874-E2E4A30F9B90

P577

Q37186448-D546AE00-DC95-4E21-99DD-A612D029B713

P5875

Q37186448-FBC9A7D1-47CD-49CD-A1F2-0921E16D4BB2

P698

Q37186448-49CE5FCE-68CF-4BC7-A446-A0AA5CF0039F

P932

Q37186448-94E02814-5C5C-4CD7-B279-665502344FFD

P356

P1433

Nature Communications

P1476

Master regulators of FGFR2 signalling and breast cancer risk

@en

P2093

Bruce A J Ponder

http://www.w3.org/2001/XMLSchema#string

Kerstin B Meyer

http://www.w3.org/2001/XMLSchema#string

Martin O'Reilly

http://www.w3.org/2001/XMLSchema#string

Mauro A A Castro

http://www.w3.org/2001/XMLSchema#string

Michael N C Fletcher

http://www.w3.org/2001/XMLSchema#string

Oscar M Rueda

http://www.w3.org/2001/XMLSchema#string

P2860

Model-based analysis of ChIP-Seq (MACS)

PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression

A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis

Genome-wide association studies identify four ER negative-specific breast cancer risk loci

Comprehensive molecular portraits of human breast tumours

Genome-wide association study identifies novel breast cancer susceptibility loci

GATA-3 and the regulation of the mammary luminal cell fate

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

P2888

P304

2464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS3464

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Florian Markowetz

Suet-feung Chin

Ines de Santiago

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256665868

http://www.w3.org/2001/XMLSchema#string

P698

24043118

http://www.w3.org/2001/XMLSchema#string

P932

3778544

http://www.w3.org/2001/XMLSchema#string